MANDATO, Claudia
 Distribuzione geografica
Continente #
AS - Asia 4.664
NA - Nord America 3.794
EU - Europa 1.225
SA - Sud America 455
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 10.183
Nazione #
US - Stati Uniti d'America 3.719
HK - Hong Kong 2.852
SG - Singapore 955
BR - Brasile 375
CN - Cina 369
IT - Italia 356
RU - Federazione Russa 240
VN - Vietnam 207
UA - Ucraina 161
IE - Irlanda 105
DE - Germania 103
TR - Turchia 53
KR - Corea 52
SE - Svezia 46
FI - Finlandia 44
GB - Regno Unito 42
IL - Israele 41
IN - India 39
MX - Messico 33
CA - Canada 31
AT - Austria 29
AR - Argentina 28
NL - Olanda 24
PL - Polonia 21
BD - Bangladesh 20
ID - Indonesia 15
EC - Ecuador 14
IQ - Iraq 14
ES - Italia 12
ZA - Sudafrica 12
JP - Giappone 11
CZ - Repubblica Ceca 10
CO - Colombia 9
FR - Francia 9
VE - Venezuela 9
PE - Perù 8
PY - Paraguay 6
EU - Europa 5
PK - Pakistan 5
UZ - Uzbekistan 5
BY - Bielorussia 4
EG - Egitto 4
KE - Kenya 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
JO - Giordania 3
LB - Libano 3
LT - Lituania 3
OM - Oman 3
SV - El Salvador 3
BE - Belgio 2
CL - Cile 2
MA - Marocco 2
MD - Moldavia 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
ML - Mali 1
MW - Malawi 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
UG - Uganda 1
YT - Mayotte 1
Totale 10.183
Città #
Hong Kong 2.846
Ann Arbor 567
Singapore 489
Dallas 325
Woodbridge 317
Chandler 288
Ashburn 248
San Jose 232
Princeton 222
Jacksonville 191
Wilmington 167
Houston 149
Dublin 97
Naples 92
Dong Ket 76
Beijing 75
Moscow 51
Los Angeles 50
Ho Chi Minh City 47
New York 42
Nanjing 41
Izmir 40
Dearborn 39
Andover 35
Boardman 35
Pellezzano 33
The Dalles 31
Salerno 30
São Paulo 29
Washington 26
Hanoi 23
Mestre 23
Brooklyn 22
Santa Clara 20
Vienna 20
Atlanta 19
Denver 19
Munich 19
Warsaw 19
Nuremberg 18
Stockholm 18
Amsterdam 17
Chicago 16
Düsseldorf 16
Shenyang 16
Seattle 15
San Francisco 14
Council Bluffs 13
Norwalk 13
Pune 13
Chennai 12
Fairfield 12
Montreal 12
London 11
Rio de Janeiro 11
Rome 11
Seoul 11
West Jordan 11
Brno 10
Hebei 10
Jiaxing 10
Tianjin 10
Tokyo 10
Ankara 9
Johannesburg 9
Mexico City 9
Columbus 8
Curitiba 8
Nanchang 8
Orem 8
Phoenix 8
San Diego 8
Haiphong 7
Poplar 7
Baghdad 6
Biên Hòa 6
Boston 6
Lappeenranta 6
Quito 6
Arba 5
Brasília 5
Caracas 5
Charlotte 5
Eboli 5
Frankfurt am Main 5
Goiânia 5
Guayaquil 5
Helsinki 5
Manaus 5
Manchester 5
Milan 5
Nola 5
Querétaro 5
Redwood City 5
Ribeirão Preto 5
Shanghai 5
Tashkent 5
Turku 5
Belo Horizonte 4
Buenos Aires 4
Totale 7.626
Nome #
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 729
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 349
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 347
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 318
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 290
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 247
A systematic review of pediatrics NAFLD therapy: year 2012 222
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 211
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 193
Humanization interventions in general pediatric wards: a systematic review 181
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 173
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 161
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 160
Atypical celiac disease presenting as obesity-related liver dysfunction. 149
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 146
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 146
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 137
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 130
Autoimmune manifestations in pediatric liver transplantation recipients 127
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 127
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 125
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 125
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 122
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 115
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 113
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 111
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 111
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 108
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 108
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 107
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 107
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 106
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 106
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 106
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 104
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 103
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 100
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 100
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 99
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 98
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 97
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 90
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 88
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 87
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 85
More on vitamin E therapy 84
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 83
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 79
Global multi-stakeholder endorsement of the MAFLD definition 73
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 72
Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024 68
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 66
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene 62
Nutrition and Liver Disease 62
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 61
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 58
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 57
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 56
Ittero e feci ipocoliche: allarme atresia delle vie biliari 54
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 53
Bassa statura non sindromica e ritardo puberale: non solo ritardo costituzionale di crescita e pubertà 52
Drug dosing in children with obesity: a narrative updated review 52
ALAGILLE SYNDROME: IS IT ALWAYS CHOLESTASIS? 51
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 51
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 51
Real-word experience with Odevixibat in children with Progressive Familial Intrahepatic Cholestasis 50
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 50
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 49
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 49
The gut-liver axis as a target of liver disease management 48
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review 47
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 46
Genetics, epigenetics and transgenerational transmission of obesity in children 45
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 45
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 43
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 43
A persistent fever associated with elevated inflammatory indices and ultrasound lesions of liver and spleen 43
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 42
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well 40
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase 39
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 39
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 39
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 39
Letter to the Editor in response to: “ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis” 37
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 37
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 36
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 36
An odd septic arthritis of the hip 36
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 35
An almost accidentally diagnosis 35
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 34
Isolated aspartate aminotransferase elevation: Is it liver disease or what else? 33
The complexity of diagnosing a drug reaction syndrome in the child|La complessità della diagnosi di una sindrome da reazione a farmaco nel bambino 33
Emerging, re‐emerging and/or atypically behaving infectious diseases 33
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 32
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 32
Bronchiolitis: Compliance with guidelines 31
Thrombotic Features as the Primary Cause of SARS-CoV-2 Related Acute Abdomen in Children 29
The C677T mutation of the 5,1O-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy 27
Nutritional therapy in liver transplantation 27
Totale 9.768
Categoria #
all - tutte 36.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.267


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021225 0 0 0 0 0 0 33 4 50 7 44 87
2021/2022360 5 0 0 3 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024533 29 48 43 25 32 89 41 24 14 43 24 121
2024/20251.193 21 22 19 54 42 190 185 100 184 101 175 100
2025/20265.406 375 1.840 1.514 322 658 282 415 0 0 0 0 0
Totale 10.377